
MRNA Stock Up 20%, Moderna Requests FDA for Emergency Clearance of COVID-19 Vaccine
On Monday, Moderna presented the latest report of its trials on a wide scale with a 94% efficacy rate as it awaits an FDA nod in the coming weeks soon to begin its vaccine rollout.